SQUEEZE
Maximizing the effectiveness of prescription drugs for rheumatoid arthritis
Project Manager
ABOUT THE PROJECT
SQUEEZE is a European consortium that has been awarded funding from Horizon Europe, the EU's research programme, to research the treatment of rheumatoid arthritis. There will be several parts of the project that address different approaches to arthritis treatment. REMEDY has the main responsibility for the part of the project that works on therapeutic drug monitoring. This includes a large randomised controlled trial, RA-DRUM.
More information about the entire SQUEEZE can be found on the consortium website:
WHO CAN JOIN?
Patients over 18 years of age diagnosed with rheumatoid arthritis. Recruitment of participants has not yet begun.
WHAT DOES THE STUDY INVOLVE?
More information about the study is coming.
This project has received funding from the European Union's Horizon Europe research and innovation program under grant agreement no. 101095052. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Unior nor the granting authority can be held responsible for them.